Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments
First Claim
1. A pharmaceutical composition comprising,HDV insulin, andone or more additional therapeutic agents not associated with HDV insulin.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention includes a pharmaceutical composition comprising HDV insulin or oral HDV insulin, and one or more additional therapeutic agents useful for the treatment of diabetes and diabetes related ailments. The present invention also includes a method of making the pharmaceutical inventions of the application. The present invention further includes methods of treating diabetes and/or diabetes related ailments comprising administering a pharmaceutical composition of the invention to a patient in need thereof. The present invention also includes methods of treating diabetes related ailments comprising administering a pharmaceutical formulation of HDV insulin or a pharmaceutical formulation of oral HDV insulin.
-
Citations
139 Claims
-
1. A pharmaceutical composition comprising,
HDV insulin, and one or more additional therapeutic agents not associated with HDV insulin.
-
4-32. -32. (canceled)
-
33. A pharmaceutical composition comprising,
oral HDV insulin, and one or more additional therapeutic agents not associated with oral HDV insulin.
-
36-64. -64. (canceled)
-
65. A method of preparing a pharmaceutical composition comprising HDV insulin and one or more additional therapeutic agents not associated with HDV insulin, said method comprising the steps of:
-
a. mixing lipid components and at least one targeting agent in aqueous media to form a first mixture; b. adding at least one insulin to said first mixture to form a second mixture; and c. formulating said second mixture with said one or more additional therapeutic agents. - View Dependent Claims (67, 68)
-
-
66. A method of preparing a pharmaceutical composition comprising oral HDV insulin and one or more additional therapeutic agents not associated with oral HDV insulin, said method comprising the steps of:
-
a. forming oral HDV insulin by; i. mixing lipid components and, optionally, at least one targeting agent in aqueous media to form a first mixture; ii. adding at least one insulin to said first mixture to form a second mixture; iii. adding said second mixture to gelatin to form a gelatin-associated mixture; iv. drying said gelatin-associated mixture to form a dry mixture of oral HDV insulin; and b. formulating said dry mixture of oral HDV insulin with said one or more additional therapeutic agents not associated with oral HDV insulin. - View Dependent Claims (98, 99)
-
-
69-97. -97. (canceled)
-
100-128. -128. (canceled)
-
130. (canceled)
-
131. A method of treating a diabetes related ailment and/or a disease or conditions other than diabetes or a diabetes related ailment in a patient in need thereof, said method comprising
administering to said patient a pharmaceutical formulation of HDV insulin or pharmaceutical formulation of oral HDV insulin, and optionally co-administering to said patient one or more additional therapeutic agents not associated with said HDV insulin or said oral HDV insulin.
-
133-134. -134. (canceled)
-
136. A kit comprising
a. a pharmaceutical composition comprising an insulin selected from the group consisting of HDV insulin and oral HDV insulin, and one or more additional therapeutic agents not associated with said insulin; - and
b. instructional material for administration of said composition to a human.
- and
-
137. (canceled)
-
138. A kit comprising
a. a pharmaceutical formulation of an insulin selected from the group consisting of HDV insulin and oral HDV insulin, and one or more additional therapeutic agents for co-administration; - and
b. instructional material for co-administration of said pharmaceutical formulation of insulin and said therapeutic agents to a human.
- and
-
139. (canceled)
Specification